1. Scrip
  2. >>R&D
  3. >>Clinical Trials

Eight Clinical Trial Read-Outs To Look Out For In Early 2018

 
• By Alexandra Shimmings

The first three months of the year should bring late-stage clinical trial read-outs for a range of novel products including Johnson & Johnson's esketamine, Esperion's bempedoic acid, ImmuPharma's Lupuzor and VBL's gene therapy for brain cancer.

Bio sample
• Source: Shutterstock

With input from Biomedtracker, Scrip highlights eight of the more interesting late-stage clinical trials due to read out in the next three months.

vTv Therapeutics Inc. is expected to announce data from the first part of the STEADFAST Phase III trial of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D